Insights on Discovery
-
Powering More Efficient Clinical Development With AI And ML
7/7/2025
Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.
-
Securing A Treatment Through Grit And Collaboration
7/3/2025
Discover how one family defied the odds—bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.
-
Ready To Demystify Organoids?
7/1/2025
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
Ethical, Considerations As Gene Editing Technologies Advance
6/26/2025
Observe as experts highlight innovative tools and strategies advancing the safety of gene editing therapies while addressing off-target effects, regulatory demands, and manufacturing efficiency.
-
How The Pharma Industry Is Closing Health Inequities
6/26/2025
Witness as pharma leaders discuss advancing equity through inclusive trial design, access planning, and global partnerships to overcome persistent health disparities and expand access to lifesaving therapies worldwide.
-
Guide To Seeding, Expanding, And Harvesting Stem Cells
6/18/2025
Investigate important considerations for working with three different stem cell types: mesenchymal stem/stromal cells, induced pluripotent stem cells, and neural stem cells.
-
What ASCO 2025 Means For The Future Of Oncology Trials
6/13/2025
Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.
-
Factors Influencing CD34+ Cell Collection Efficiency In Leukapheresis
6/3/2025
Efficiently collecting sufficient peripheral blood stem cells is paramount for successful transplantation, necessitating a deeper understanding of influencing factors and procedural nuances.
-
Broad Biodistribution And Expression Of Allele-Selective LETI-101
5/28/2025
Discover how LETI-101, a novel precision-based CRISPR treatment, can leverage targeted delivery and broad brain distribution to transform Huntington's disease treatment.
-
CRISPR Portfolio, Modalities Accelerate Candidate Identification
5/28/2025
See how this cutting-edge, AI-driven genome editing technology can accelerate the development of precise, clinically viable therapies for genetic diseases.